We are live on ! Find out more
CCC

Crescent Capital Consulting Portfolio holdings

AUM $607M
1-Year Est. Return 22.88%
This Fund
S&P 500
This Quarter Est. Return
+6.59%
1 Year Est. Return
+22.88%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$534M
AUM Growth
+$78.2M
Cap. Flow
+$75.8M
Cap. Flow %
14.19%
Top 10 Hldgs %
38.48%
Holding
571
New
47
Increased
80
Reduced
111
Closed
70
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IWM icon
26
iShares Russell 2000 ETF
IWM
$79.8B
$5.09M 0.95%
22,200
-1,149
-5% -$258K
IWP icon
27
iShares Russell Mid-Cap Growth ETF
IWP
$19.8B
$5.03M 0.94%
44,460
-8,219
-16% -$878K
VCR icon
28
Vanguard Consumer Discretionary ETF
VCR
$6.15B
$4.93M 0.92%
15,684
+14,850
+1,781% +$4.55M
IWO icon
29
iShares Russell 2000 Growth ETF
IWO
$14.3B
$4.82M 0.9%
15,469
-2,672
-15% -$804K
IJT icon
30
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.26B
$4.79M 0.9%
36,125
-8,928
-20% -$1.16M
IJK icon
31
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.7B
$4.76M 0.89%
58,876
-13,830
-19% -$1.11M
KO icon
32
Coca-Cola
KO
$377B
$4.35M 0.81%
80,398
-280
-0.3% -$15.2K
IBB icon
33
iShares Biotechnology ETF
IBB
$9.34B
$4.34M 0.81%
26,542
+3,325
+14% +$512K
LLY icon
34
Eli Lilly
LLY
$1.02T
$4.09M 0.77%
17,823
-207
-1% -$41.6K
DVYE icon
35
iShares Emerging Markets Dividend ETF
DVYE
$1.22B
$3.93M 0.74%
101,018
+18,580
+23% +$741K
XSVM icon
36
Invesco S&P SmallCap Value with Momentum ETF
XSVM
$674M
$3.89M 0.73%
76,618
+72,668
+1,840% +$3.67M
PG icon
37
Procter & Gamble
PG
$336B
$3.8M 0.71%
28,219
-46
-0.2% -$6.22K
XMVM icon
38
Invesco S&P MidCap Value with Momentum ETF
XMVM
$502M
$3.73M 0.7%
82,393
+78,083
+1,812% +$3.63M
AMZN icon
39
Amazon
AMZN
$2.92T
$3.64M 0.68%
21,180
+1,000
+5% +$166K
IWN icon
40
iShares Russell 2000 Value ETF
IWN
$14.3B
$3.43M 0.64%
20,708
-8,261
-29% -$1.36M
XOM icon
41
ExxonMobil
XOM
$644B
$3.41M 0.64%
53,975
-2,867
-5% -$171K
MRK icon
42
Merck
MRK
$322B
$3.4M 0.64%
43,747
-3,405
-7% -$253K
VHT icon
43
Vanguard Health Care ETF
VHT
$18.1B
$3.4M 0.64%
13,757
-7,628
-36% -$1.82M
JNJ icon
44
Johnson & Johnson
JNJ
$618B
$3.32M 0.62%
20,152
-596
-3% -$98.7K
HD icon
45
Home Depot
HD
$331B
$3.18M 0.6%
9,974
-19
-0.2% -$6.04K
ACWI icon
46
iShares MSCI ACWI ETF
ACWI
$32.9B
$3.1M 0.58%
30,660
+29
+0.1% +$2.89K
IJS icon
47
iShares S&P Small-Cap 600 Value ETF
IJS
$8.12B
$2.93M 0.55%
27,818
-13,653
-33% -$1.43M
IWS icon
48
iShares Russell Mid-Cap Value ETF
IWS
$15.6B
$2.91M 0.55%
25,342
-11,143
-31% -$1.28M
IJJ icon
49
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.83B
$2.87M 0.54%
27,211
-13,176
-33% -$1.41M
GLD icon
50
SPDR Gold Trust
GLD
$131B
$2.8M 0.52%
16,910
-5,882
-26% -$999K

Similar funds

Crescent Capital Consulting's Q2 2021 Portfolio in Review

As of Q2 2021, Crescent Capital Consulting held 571 positions worth $534M, up 17% from $456M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Crescent Capital Consulting deployed $75.8M of net new capital in Q2 2021, opening 47 new positions and adding to 80 existing holdings. Its largest new stake was Invesco BulletShares 2023 High Yield Corporate Bond ETF: 613,192 shares worth $15.6M.

By sector, the portfolio is most concentrated in Technology at 5.1% of assets, down from 5.5% a quarter earlier, followed by Healthcare and Materials.

On the sell side, the largest reduction was Invesco BulletShares 2021 High Yield Corporate Bond ETF, an estimated $10.8M trimmed.

  • Crescent Capital Consulting's largest Q2 2021 buy was Invesco BulletShares 2023 High Yield Corporate Bond ETF: 613,192 shares worth $15.6M.
  • Crescent Capital Consulting added most to iShares Russell 1000 Growth ETF in Q2 2021, an estimated $27.1M increase.
  • Crescent Capital Consulting's biggest Q2 2021 reduction was Invesco BulletShares 2021 High Yield Corporate Bond ETF, cutting an estimated $10.8M.
  • Crescent Capital Consulting fully exited State Street SPDR Bloomberg Short Term High Yield Bond ETF in Q2 2021, selling an estimated $273K.
  • Crescent Capital Consulting's ten largest holdings make up 38% of its $534M portfolio in Q2 2021.
  • Crescent Capital Consulting opened 47 new positions and closed 70 in Q2 2021.
  • Crescent Capital Consulting's portfolio value rose 17% quarter-over-quarter to $534M.

Based on Crescent Capital Consulting's 13F filing for Q2 2021, filed 15 Jul 2021.